Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$15.94 USD
+0.96 (6.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.37 -0.57 (-3.58%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
AVTX 15.94 +0.96(6.41%)
Will AVTX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AVTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AVTX
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
Will Avalo Therapeutics, Inc. (AVTX) Report Negative Q4 Earnings? What You Should Know
AVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates
Avalo (AVTX) to Report Q4 Earnings: What's in the Cards?
New Strong Buy Stocks for January 3rd
Other News for AVTX
Oppenheimer more bullish on Avalo Therapeutics, upgrades to Outperform
Oppenheimer gets more bullish on Avalo Therapeutics, upgrades shares
12 Health Care Stocks Moving In Tuesday's After-Market Session
SOL, MESO and ACOR among pre-market losers
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session